Literature DB >> 11306197

Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache.

R Lodi1, S Iotti, P Cortelli, G Pierangeli, S Cevoli, V Clementi, S Soriani, P Montagna, B Barbiroli.   

Abstract

We used phosphorus magnetic resonance spectroscopy to assess in vivo the brain cytosolic free magnesium concentration and the free energy released by the reaction of adenosine triphosphate (ATP) hydrolysis (DeltaG(ATPhyd)), the latter being an index of the cell's bioenergetics condition. We studied 78 patients with migraine in attack-free periods (7 with migraine stroke, 13 with migraine with prolonged aura, 37 with migraine with typical aura or basilar migraine, and 21 with migraine without aura), and 13 patients with cluster headache. In the occipital lobes of all subgroups of migraine and in cluster headache patients cytosolic free [Mg(2+)] as well as the free energy released by the reaction of ATP hydrolysis were significantly reduced. Among migraine patients, the level of free energy released by the reaction of ATP hydrolysis and the cytosolic free [Mg(2+)] showed a trend in keeping with the severity of clinical phenotype, both showing the lowest values in patients with migraine stroke and the highest in patients with migraine without aura. These results support our current hypothesis that the reduction in free [Mg(2+)] in tissues with mitochondrial dysfunction is secondary to the bioenergetics deficit, and are against a primary role of low brain cytosolic free [Mg(2+)] in causing the bioenergetics deficit in headache.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306197     DOI: 10.1016/s0361-9230(01)00440-3

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  26 in total

Review 1.  Nutraceuticals and Behavioral Therapy for Headache.

Authors:  Rebecca Barmherzig; Thilinie Rajapakse
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

2.  Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field.

Authors:  Nastaren Abad; Jens T Rosenberg; Tangi Roussel; Dillon C Grice; Michael G Harrington; Samuel C Grant
Journal:  Magn Reson Med       Date:  2017-09-17       Impact factor: 4.668

Review 3.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 4.  Carnitine Responsive Migraine Headache Syndrome: Case Report and Review of the Literature.

Authors:  Larry Charleston; Suad Khalil; William B Young
Journal:  Curr Pain Headache Rep       Date:  2021-03-23

Review 5.  Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Authors:  Jonathan M Borkum
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

6.  Migraine: an overview.

Authors:  Salvatore Salomone; Filippo Caraci; Anna Capasso
Journal:  Open Neurol J       Date:  2009-10-01

7.  Prevalence and risk of migraine headaches in adult fragile X premutation carriers.

Authors:  J Au; R S Akins; L Berkowitz-Sutherland; H-T Tang; Y Chen; A Boyd; F Tassone; D V Nguyen; R Hagerman
Journal:  Clin Genet       Date:  2013-02-21       Impact factor: 4.438

Review 8.  The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review.

Authors:  Serena L Orr
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

9.  Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjects.

Authors:  M G Bischof; V Mlynarik; A Brehm; E Bernroider; M Krssak; E Bauer; C Madl; M Bayerle-Eder; W Waldhäusl; M Roden
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

Review 10.  Advanced Imaging in the Evaluation of Migraine Headaches.

Authors:  Benjamin M Ellingson; Chelsea Hesterman; Mollie Johnston; Nicholas R Dudeck; Andrew C Charles; Juan Pablo Villablanca
Journal:  Neuroimaging Clin N Am       Date:  2019-02-19       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.